Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by WCM Investment Management LLC

WCM Investment Management LLC lessened its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 1.9% in the 4th quarter, Holdings Channel.com reports. The fund owned 512,057 shares of the company’s stock after selling 10,027 shares during the period. WCM Investment Management LLC’s holdings in Surgery Partners were worth $10,533,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Principal Financial Group Inc. purchased a new position in shares of Surgery Partners in the 3rd quarter valued at approximately $1,469,000. King Street Capital Management L.P. acquired a new position in Surgery Partners during the 3rd quarter valued at approximately $46,748,000. Royce & Associates LP raised its holdings in shares of Surgery Partners by 12.2% in the third quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after buying an additional 55,545 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Surgery Partners by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after buying an additional 42,897 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after buying an additional 777,038 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. reduced their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Macquarie restated an “outperform” rating and issued a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. Bank of America started coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They issued a “buy” rating and a $38.00 price target on the stock. Finally, Royal Bank of Canada decreased their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $36.56.

Surgery Partners Price Performance

NASDAQ:SGRY opened at $25.80 on Monday. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The company has a 50 day moving average price of $21.84 and a 200-day moving average price of $26.93. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $35.29. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of -53.75, a price-to-earnings-growth ratio of 17.77 and a beta of 2.60.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. During the same period in the previous year, the firm posted $0.15 EPS. The firm’s quarterly revenue was up 14.3% on a year-over-year basis. Equities research analysts forecast that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.